TVGN sentiment intelligence

Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks

Tone

Neutral 50/100

Event

Earnings

Published

15 Jul 2026 07:00

Source

StockStory

Dr. Saadi boosts control at Tevogen Bio Holdings (TVGN) with stock grant

Dr. Ryan H. Saadi, CEO of Tevogen Bio Holdings (TVGN), has increased his beneficial ownership to 59.7% of the company's common stock, totaling 3,709,567 shares. This surge in control stems from a restricted stock grant of 1,220,000 shares received on July 10, 2026, as compensatio

Tone

Neutral 50/100

Event

Market update

Published

15 Jul 2026 02:13

Source

Stock Titan

Form 13D/A Tevogen Bio Holdings Inc. For: 14 July By Investing.com

This article reports that Tevogen Bio Holdings Inc. has filed a Form 13D/A on July 14, 2026. This SEC filing indicates a change in beneficial ownership of the company's shares.

Tone

Neutral 50/100

Event

Market update

Published

15 Jul 2026 02:00

Source

Investing.com Nigeria

Tevogen Bio Announces 2026 Annual Meeting of Stockholders

Tevogen Bio Holdings Inc. (Nasdaq: TVGN) has announced its 2026 Annual Meeting of Stockholders will be held virtually on Monday, August 24, 2026. Stockholders of record as of July 23, 2026, will be eligible to vote. The company also provided deadlines for stockholder proposals an

Tone

Neutral 50/100

Event

Market update

Published

14 Jul 2026 23:44

Source

BioSpace

Price to book forward of Tevogen Bio Holdings Inc. – NASDAQ:TVGNW

The article focuses on the "Price to book forward" for Tevogen Bio Holdings Inc., traded on NASDAQ under the symbol TVGNW. It appears to be an entry from a financial data platform like TradingView, providing specific financial metrics for the company. The content primarily lists

Tone

Neutral 50/100

Event

Market update

Published

14 Jul 2026 20:40

Source

TradingView

Tevogen stockholders face a July 23 deadline to submit proposals

Tevogen Bio (Nasdaq: TVGN) has announced its 2026 Annual Meeting of Stockholders for Monday, August 24, 2026, to be held virtually. Stockholders of record as of July 23, 2026, are eligible to vote. Due to the meeting date being more than one year after the previous meeting, stock

Tone

Neutral 50/100

Event

Market update

Published

14 Jul 2026 02:12

Source

Stock Titan

Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks

Tone

Neutral 50/100

Event

Earnings

Published

13 Jul 2026 12:30

Source

Market source

Tevogen Bio Holdings(TVGN) Stock Options Chain | Quotes & News

Tone

Neutral 50/100

Event

Market update

Published

12 Jul 2026 20:14

Source

Moomoo

Tevogen Bio (TVGN) awards director 40,000 restricted shares tied to revenue goals

Tevogen Bio Holdings Inc. Director Goh Keow Lin was granted 40,000 restricted common shares under the 2024 Omnibus Incentive Plan. These shares vest in three equal installments upon reaching specified anniversaries of the grant date or aggregate revenue milestones of $50 million,

Tone

Neutral 50/100

Event

Earnings

Published

10 Jul 2026 23:10

Source

Stock Titan

Tevogen Bio (TVGN) awards CFO 40,000 restricted shares with revenue vesting targets

Tevogen Bio Holdings Inc. (TVGN) has granted its CFO, Kirti Desai, 40,000 restricted shares of common stock at no cost. These shares will vest in three equal tranches, contingent on both service anniversaries and the company achieving aggregate revenue targets of $50 million, $10

Tone

Neutral 50/100

Event

Earnings

Published

10 Jul 2026 22:40

Source

Stock Titan

Tevogen Bio (TVGN) awards 40,000 restricted shares to director Feike

Tevogen Bio (TVGN) director Jeffrey L. Feike was granted 40,000 restricted common shares under the company's 2024 Omnibus Incentive Plan. These shares, valued at $0.00 per share, will vest in three equal installments tied to both service anniversaries and Tevogen Bio achieving ag

Tone

Neutral 50/100

Event

Market update

Published

10 Jul 2026 22:40

Source

Stock Titan

Tevogen Bio (TVGN) awards 40,000 restricted stock shares to director Victor J. Sordillo

Tevogen Bio (TVGN) has granted 40,000 shares of restricted common stock to director Victor J. Sordillo under its 2024 Omnibus Incentive Plan. These shares were awarded at no cost and will vest in three equal installments, subject to service-based anniversaries and the company ach

Tone

Neutral 50/100

Event

Market update

Published

10 Jul 2026 22:11

Source

Stock Titan

Form 4 Tevogen Bio Holdings Inc For: 10 July By Investing.com

This article from Investing.com reports on a Form 4 filing for Tevogen Bio Holdings Inc. dated July 10. The filing indicates insider trading activity for the company. The stock symbol TVGN is mentioned with a performance of -10.28%.

Tone

Neutral 50/100

Event

Market update

Published

10 Jul 2026 22:11

Source

Investing.com Nigeria

[Form 4] Tevogen Bio Holdings Inc. Insider Trading Activity

Tevogen Bio Holdings Inc. Director Curtis L. Patton reported an acquisition of 40,000 shares of restricted common stock through a Form 4 filing. The shares were granted under the company’s 2024 Omnibus Incentive Plan, with vesting tied to service requirements and revenue mileston

Tone

Neutral 50/100

Event

Deals and strategy

Published

10 Jul 2026 21:09

Source

Stock Titan

Tevogen Bio (TVGN) awards 40,000 performance-based restricted shares to director

Tevogen Bio Holdings Inc. (TVGN) has granted director Susan M. Podlogar 40,000 performance-based restricted shares under its 2024 Omnibus Incentive Plan. These shares vest in three equal installments, contingent on both continued service and the company achieving aggregate revenu

Tone

Neutral 50/100

Event

Market update

Published

10 Jul 2026 21:09

Source

Stock Titan

Tevogen Bio (TVGN) grants CEO Ryan Saadi 1.22M restricted stock units

Tevogen Bio Holdings Inc. (TVGN) has granted its CEO, Ryan H. Saadi, 1,220,000 shares of restricted common stock under the company's 2024 Omnibus Incentive Plan. These shares will vest in four equal annual installments starting July 10, 2033, contingent on his continued service.

Tone

Neutral 50/100

Event

Market update

Published

10 Jul 2026 21:09

Source

Stock Titan

Enterprise value to EBITDA forward of Tevogen Bio Holdings Inc. – FWB:G280

The article focuses on the Enterprise Value to EBITDA forward for Tevogen Bio Holdings Inc. (FWB:G280), traded on the Frankfurt Stock Exchange. It appears to be a financial data point or analysis provided by a platform like TradingView, indicating a key valuation metric for the b

Tone

Neutral 50/100

Event

Market update

Published

27 Jun 2026 20:09

Source

TradingView

Enterprise value to EBIT forward of Tevogen Bio Holdings Inc. – NASDAQ:TVGN

This article displays the forward Enterprise Value to EBIT for Tevogen Bio Holdings Inc. (NASDAQ: TVGN) on the TradingView platform. It presents financial data for the company, accessible through the "Financials" section of its profile.

Tone

Neutral 50/100

Event

Market update

Published

26 Jun 2026 21:40

Source

TradingView

Enterprise value to revenue forward of Tevogen Bio Holdings Inc. – NASDAQ:TVGN

This article provides an "Enterprise value to revenue forward" metric for Tevogen Bio Holdings Inc., traded on NASDAQ under the symbol TVGN. The content is primarily a data point placeholder from TradingView, indicating the value and change of this financial metric. It does not o

Tone

Neutral 50/100

Event

Earnings

Published

26 Jun 2026 20:39

Source

TradingView

Enterprise value to revenue forward of Tevogen Bio Holdings Inc. – FWB:G280

This article provides financial data for Tevogen Bio Holdings Inc. (FWB:G280), specifically focusing on its enterprise value to revenue forward. The content appears to be a financial data snippet from TradingView, offering a snapshot of the company's valuation metric on the Frank

Tone

Neutral 50/100

Event

Earnings

Published

26 Jun 2026 19:40

Source

TradingView

Tevogen Bio (NASDAQ: TVGN) registers 375,000 shares for resale by Patel Family

Tevogen Bio (NASDAQ: TVGN) has registered up to 375,000 shares of common stock for resale by a selling stockholder, the Patel Family, through a prospectus filed with the SEC. These shares are issuable upon the exercise of Pre-Funded Warrants issued in May 2026. Tevogen Bio will n

Tone

Neutral 50/100

Event

Market update

Published

26 Jun 2026 13:10

Source

Stock Titan

Price to book forward of Tevogen Bio Holdings Inc. – NASDAQ:TVGN

The article presents the "Price to book forward" financial metric for Tevogen Bio Holdings Inc. (NASDAQ: TVGN). It appears to be an entry on a financial data platform like TradingView, displaying key financial information for the biotechnology company. The content also includes e

Tone

Neutral 50/100

Event

Market update

Published

26 Jun 2026 10:10

Source

TradingView

[EFFECT] Tevogen Bio Holdings Inc. SEC Filing

Tevogen Bio Holdings Inc. (NASDAQ: TVGN) has filed an EFFECT form with the SEC, indicating that a previous filing (Form S-3 shelf registration) has become effective. The filing shows an effectiveness date of June 25, 2026, at 4:30 P.M. UTC, making the company's previously filed s

Tone

Neutral 50/100

Event

Market update

Published

26 Jun 2026 10:10

Source

Stock Titan

Price to sales forward of Tevogen Bio Holdings Inc. – FWB:G280

The article provides a financial overview of Tevogen Bio Holdings Inc. (FWB:G280) on the Frankfurt Stock Exchange, specifically focusing on its price-to-sales forward metric. It indicates that the market was closed at the time of publication with no trades, and the information is

Tone

Neutral 50/100

Event

Market update

Published

26 Jun 2026 02:10

Source

TradingView

Price to earnings forward of Tevogen Bio Holdings Inc. – FWB:G280

This article provides financial data for Tevogen Bio Holdings Inc. (FWB:G280) on TradingView. It specifically highlights the company's price to earnings forward metric. The market for this stock is currently closed with no trades.

Tone

Neutral 50/100

Event

Earnings

Published

26 Jun 2026 01:09

Source

TradingView

Tevogen Bio Holdings Inc (TVGN) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Tevogen Bio Holdings Inc (TVGN), outlining future EPS and revenue growth estimates. It notes that relevant financial data for the company's earnings, revenue, net profit, and EBIT forecasts have not yet been disclosed by the company.

Tone

Neutral 50/100

Event

Earnings

Published

22 Jun 2026 15:41

Source

TradingKey

Tevogen Bio Holdings Inc (TVGNW) Institutional Confidence

The article details the institutional confidence in Tevogen Bio Holdings Inc (TVGNW), providing a list of institutional shareholders and their shareholdings. The stock is currently trading at $0.041, down 16.36%, with institutional confidence being one of the key metrics assessed

Tone

Neutral 50/100

Event

Market update

Published

18 Jun 2026 10:09

Source

TradingKey

Tevogen Bio Holdings Inc (TVGNW) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis for Tevogen Bio Holdings Inc (TVGNW), detailing key financial metrics such as P/E, P/B, P/S, and P/CF ratios. It indicates that relevant data for these metrics have not yet been disclosed by the company. The report also includes current

Tone

Neutral 50/100

Event

Market update

Published

18 Jun 2026 10:09

Source

TradingKey

Tevogen Bio Holdings Inc (TVGN) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of Tevogen Bio Holdings Inc (TVGN), showing its current stock price and market capitalization. It notes that relevant data for key valuation metrics like P/E, P/B, P/S, and P/CF ratios have not yet been disclosed by the company. The over

Tone

Neutral 50/100

Event

Market update

Published

18 Jun 2026 06:10

Source

TradingKey